Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters

@article{Chu2008MetabolismAR,
  title={Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters},
  author={Xiaoyan Chu and Yuexia Liang and Xiaoxin Cai and Karla G. Cuevas-Licea and Ronda K. Rippley and Kelem Kassahun and Magang Shou and Matthew P. Braun and George A. Doss and M. Reza Anari and Raymond Evers},
  journal={Pharmaceutical Research},
  year={2008},
  volume={26},
  pages={459-468}
}
PurposeGaboxadol, a selective extrasynaptic agonist of the delta-containing γ-aminobutyric acid type A (GABAA) receptor, is excreted in humans into the urine as parent drug and glucuronide conjugate. The goal of this study was to identify the UDP-Glucuronosyltransferase (UGT) enzymes and the transporters involved in the metabolism and active renal secretion of gaboxadol and its metabolite in humans.Methods. The structure of the glucuronide conjugate of gaboxadol in human urine was identified by… 
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
TLDR
The aim of this review is to compile the understanding of transporter-mediated disposition of phase II conjugates, which includes the literature on hepatic, intestinal and renal uptake transporters participating in the transport of glucuronide and sulfate metabolites of drugs, other xenobiotics and endobiotics.
5-Hydroxy-L-tryptophan alters gaboxadol pharmacokinetics in rats: involvement of PAT1 and rOat1 in gaboxadol absorption and elimination.
Effect of Efavirenz on UDP-Glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 Activities in Human Liver Microsomes
TLDR
In vitro results suggest that efavirenz should be examined for potential pharmacokinetic drug interactions in vivo due to strong inhibition of UGT1A4 and UGT 1A9.
Transcriptional regulation of human UDP-glucuronosyltransferase genes
TLDR
A review of published UGT gene transcriptional studies and the experimental models and tools utilized in these studies, and describes in detail the TFs and their respective CREs that have been identified in the promoters and/or enhancers of individual UGT genes.
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.
TLDR
The latter part of this review provides an in-depth analysis of the known and predicted functions of UGT3 and UGT8 enzymes, focused on their likely roles in modulation of levels of endogenous signaling pathways.
Quantitative Profiling of Human Renal UDP-glucuronosyltransferases and Glucuronidation Activity: A Comparison of Normal and Tumoral Kidney Tissues
TLDR
An extensive profiling of glucuronidation metabolism in normal and tumor kidneys using targeted mass spectrometry quantification of human UGTs demonstrates that renal drug metabolism is predominantly mediated by UGT1A9 and UGT2B7 and is greatly reduced in kidney tumors.
Effect of Honokiol on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes
TLDR
In vitro results indicate that honokiol has the potential to cause pharmacokinetic drug interactions with other co-administered drugs metabolized by CYP1A2, CYP2C8, CYB2C9, CYp2C19, and UGT1A9.
Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells.
Organic anion, organic cation and zwitterion transporters of the SLC22 and SLC47 superfamily (OATs, OCTs, OCTNs and MATEs)
TLDR
OCT3 is preferentially expressed in brain regions that belong to monoamine pathways and it is considered to play an important role in stress and in the pathogenesis of depression; it has potential to become a new antidepression drug target.
Extrahepatic metabolism at the body's internal–external interfaces
TLDR
This review summarizes the knowledge on the expression of phase I and phase II XMEs and transporters in extrahepatic tissues at the body's internal–external interfaces in the lung, kidney, bladder and skin.
...
...

References

SHOWING 1-10 OF 43 REFERENCES
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
TLDR
Characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome.
Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats.
TLDR
It is concluded that multiple transporters, including cMOAT, are responsible for the biliary excretion of CPT-11 and its metabolites (anionic forms), and the contribution of each transporter differs greatly, depending on the substrates.
Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
TLDR
The pharmacogenomic implication of polymorphic UGTs is presented, more specifically the role of UGT polymorphisms in modifying cancer risk and their impact on individual risk to drug-induced toxicities.
Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide.
TLDR
The results suggest that Mrp4, together with other unknown transporters, accounts for the luminal efflux of HCT and furosemide from proximal tubular epithelial cells.
Involvement of MRP4 (ABCC4) in the Luminal Efflux of Ceftizoxime and Cefazolin in the Kidney
TLDR
The results suggest that Mrp4 is involved in the tubular secretion of ceftizoxime and cefazolin, in concert with basolateral uptake transporters.
Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione.
TLDR
It is demonstrated that human ABCC4 in the presence of physiological concentrations of GSH has a high affinity for the taurine and glycine conjugates of the common natural bile acids as well as the unconjugated bile acid cholate.
Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein
TLDR
The data indicate that sitagliptin is unlikely to be a perpetrator of drug-drug interactions with Pgp, hOAT1, or hOat3 substrates at clinically relevant concentrations, and the effects may not be clinically meaningful, due to the high safety margin of sitgliptin.
Role of P-glycoprotein in drug disposition.
TLDR
P-glycoprotein, which is coded by human MDR1 (multidrug resistance) gene, is an energy-dependent efflux pump that exports its substrates out of the cell, which regulates the renal tubular secretion and brain distribution of digoxin.
Transport of Ethinylestradiol Glucuronide and Ethinylestradiol Sulfate by the Multidrug Resistance Proteins MRP1, MRP2, and MRP3
TLDR
The studies demonstrate specific active transport of a pharmacologically relevant drug conjugate by human MRP2 and MRP3, involving complex interactions with other organic anions and suggest that caution needs to be taken when using only competition studies as screening tools to identify substrates or inhibitors of MRP-mediated transport.
Effects of renal failure on drug transport and metabolism.
...
...